Vitrolife

Excellence in reproductive health Today, we support customers worldwide - always with sustainability in mind. We are your committed partner for the IVF journey.

Vitrolife is committed to supporting successful treatment outcomes and has been dedicated to IVF since 1994, when the field was still young. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services for fertility clinics, founded in 2011. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire fertility journey, providing consistent performance and guaranteed quality. We are a sustainable market leader and aim to be the preferred partner to the fertility clinics by providing superior products and services. Currently, Vitrolife Group are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 110 countries, through our own presence in 32 countries, and a network of distributors. Our vision is to enable people to fulfil the dream of having a healthy baby), and we achieve this by supporting our customers in delivering successful treatment outcomes. Our mission is to be the leading global partner in reproductive health, striving for better treatment outcomes for patients. Together we create excellence in reproductive health. We can help you maximise success. – Together. All the way. The Vitrolife AB (publ) share is listed on Nasdaq Stockholm.

22/12/2025

As 2025 comes to a close, we want to thank our partners, customers, and colleagues around the world for your collaboration. Your trust and dedication inspire us every day, and together, we remain committed to advancing reproductive health and helping people around the world to fulfil the dream of having a healthy baby 🤍

We wish you a joyful holiday season filled with peace, joy and time with loved ones, and we look forward to the opportunities 2026 will bring!

18/12/2025

💡Latest eWitness enhancements: Designed for the realities of the IVF Lab

IVF laboratories operate in highly regulated, high-risk environments where manual processes can add unnecessary complexity. The latest eWitness release is designed to directly address these challenges, in a practical, workflow-focused way.

With seamless EmbryoScope integration, customisable KPI dashboards, and photo capture for documentation, embryologists gain clearer visibility and traceability without disrupting critical tasks. Flexible witness and overrule options support clinical decision-making while customisable misscan reasons and release note pop-ups help reduce manual errors and training gaps.

Each enhancement is purpose-built to minimise risk, improve efficiency, and support embryologists In delivering safe, confident care at every step of the cycle.

Discover what's new in eWitness and how these enhancements are helping IVF labs meet everyday challenges with confidence:
👉 https://ow.ly/Htx150XLm5e

11/12/2025

Safeguard every IVF cycle with confidence for a trusted, stress-free workflow 💡

In today’s IVF clinics, managing a high workload, complex manual procedures, and fragmented and data handling places considerable demands on clinical teams, where even the smallest mix-up can have a lasting impact, not just operationally, but also on patients hope for a family.

eWitness supports and safeguards your processes by automating, recording, and validating each critical step, ensuring complete traceability and compliance with both European Society of Human Reproduction and Embryology (ESHRE) guidelines and the new EU SoHo Regulation - Europe’s law for the safe management of substances of human origin in assisted reproduction. By streamlining workflows, eWitness mitigates the risk of mix-ups and errors, helping empower embryologists to deliver peace of mind, not only for themselves, but most importantly, for their patients and families.

Discover how eWitness brings confidence through complete traceability for your lab and your patients:
👉https://www.vitrolife.com/products/electronic-witnessing/ewitness/?utm_source=Instagram&utm_medium=social+&utm_campaign=eWitness_release

09/12/2025

Seasonal giving: Supporting the IFFS More Joy Campaign

The vision of Vitrolife Group is to enable people to fulfil their dream of having a healthy baby. That belief inspires our actions, motivating us to extend our support and to make a positive impact.

Each year, we make a seasonal donation to a charity close to our hearts. This year, we’re proud to support the IFFS More Joy campaign, run by the International Federation of Fertility Societies (IFFS). This global campaign is dedicated to raising awareness and drive policy change that will make fertility care more affordable, accessible, and equitable. Together, we strive to bring hope, support, and joy to families around the world 🤍

Read more about the More Joy campaign here: https://ow.ly/R7We50XCOIQ

08/12/2025

We are delighted to wrap up our participation in this year's MEFS, an event that brought together inspiring conversations and innovative ideas from across the field. Over the past few days, our team had the privilege of engaging in meaningful discussions, exchanging knowledge, and connecting with professionals who share our commitment to advancing reproductive health.

We sincerely appreciate everyone who took the time to visit us, engage with our team, and contribute to the vibrant atmosphere of MEFS 2025! 🤍

21/11/2025

We're proud to wrap up the first-ever Vitrolife Group Embryology Summit! 🤍

Building on the excellent relationships with UZ Brussels and Hygeia IVF Embryogenesis, the aim was to expand our collaboration to form a re-occurring yearly platform of knowledge sharing, involving key clinics in EMEIA. This first summit was held in the Brussels IVF clinic.

Special thanks to all participants for your energizing discussions and insights! To quote Ioannis Sfontouris from Hygea IVF Embryogenesis; “This type of collaboration between the industry and the academia is not just nice to have, it's a need to have”.

Let’s continue shaping the future of embryology, together. Stay tuned for next year’s summit!

20/11/2025

Celebrating World Children’s Day! 🤍

World Children’s Day was first established in 1954 as Universal Children's Day. This meaningful occasion is dedicated to promote international togetherness, awareness among children worldwide, and improving children's welfare.

At Vitrolife Group, we believe that every child represents a brighter tomorrow. Today, we celebrate the incredible potential of children worldwide and reaffirm our commitment to creating opportunities for families to grow. Through innovation and dedication, we are committed to helping families experience the happiness of parenthood. Let’s unite in our efforts to care for, uplift, and empower the next generation who will shape our collective future.

19/11/2025

💡What is the clinical outcome of using EmbryoGlue?

Clinical studies show that using EmbryoGlue during embryo transfer can improve both pregnancy and live birth rates¹. We have summarised the strongest clinical evidence of EmbryoGlue which demonstrate its effect and safety.

Click on the link to download: https://ow.ly/7eFP50XqWYB

18/11/2025

💡"Advancing IVF with Vitrolife Group Technology & Genetic Solutions" - a successful workshop in Düsseldorf!

We were thrilled to welcome our valued customers, IVF doctors, embryologists, medical and lab directors who actively participated throughout the workshop highlighting Time-Lapse, AI-assisted iDAScore, and eWitness along with an overview of our genetics services. Our product experts Francesca Bahr, Clément Ongenae, and Heidrun Kobernick shared key data, figures and real-world insights on the products with live demos and on-the-spot answers to customer questions.

Special thanks to our speaker Ioannis Sfontouris, PhD, from Hygeia IVF embryogenesis who shared the full iDAScore clinic experience, demonstrating how it has improved embryologist efficiency, work reliability and outcomes at their clinic. Charles Kentzinger and Simona Cionca also provided an informative overview of our genetics services.

We thank everyone who attended and look forward to more workshops in the future! 🤍

12/11/2025

Trusted by Clinics. Proven by Data 💡

EmbryoScope is the most scientifically documented time-lapse system in IVF – boosting capacity, efficiency, and clinical outcomes.

Why choose Time-lapse? Studies shows:

💡Improved embryo quality
💡Embryo evaluation tools provide valuable decision support
💡Optimises laboratory workflow

University of California San Francisco’s (UCSF) currently performs 3.000 IVF cycles annually and has implemented 7 EmbryoScopes. In our case studie you can learn about how they leveraged this technology to optimise workflow, reduce potential errors, and enhance both staff and patient satisfaction while maintaining their industry-leading success rates.

Link in bio to download 👆

Adress

Gustaf Werners Gata 2
Västra Frölunda
42132

Webbplats

https://www.vitrolife.com/

Aviseringar

Var den första att veta och låt oss skicka ett mail när Vitrolife postar nyheter och kampanjer. Din e-postadress kommer inte att användas för något annat ändamål, och du kan när som helst avbryta prenumerationen.

Vill du placera din praktik längst upp i Klinik-listan i Västra Frölunda?

Dela

Typ

Leverantör av medicinsk utrustning

Together. All the way.

Vitrolife was established in Sweden in 1994 when the field of assisted reproduction was still young. The possibility to help people become parents through assisted reproduction became a reality in the 1960s, following the development of a method for fertilising eggs outside the body. The birth of Louise Brown in 1978 – the first baby born as a result of in vitro fertilisation (IVF) – gave new hope to men and women suffering from infertility. As IVF techniques developed, the importance of individual components on IVF success began to be understood. The founders of Vitrolife realised the value of using culture media with consistent and repeatable performance; the manufacturing and delivering of LOTto-LOT consistency they developed is still significant for Vitrolife today. Through well-executed product development, consistent quality controls and the acquisition of other innovative IVF companies, Vitrolife has grown with the market globally. As a result, Vitrolife provides an unbroken chain of quality products, securing results at every step of IVF treatment. Only Vitrolife can guarantee every link in this chain. Our commitment to increase pregnancy rates has never been more dedicated. Together with equally devoted clinics, we are improving IVF success and fulfilling more couples’ greatest dream. We are very proud to be a part of making this happen.